相关实验视频

Updated: May 25, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

脂类-siRNA结合物向高PD-L1表达,作为潜在的新型免疫检查点抑制剂

Rina Tansou¹, Takanori Kubo¹, Haruka Nishida¹

¹Laboratory of Molecular Cell Biology, Department of Life Science, Faculty of Pharmacy, Yasuda Women's University, Hiroshima 731-0153, Japan.

|February 26, 2025

概括

我们开发了新型的脂质-siRNA结合体,准编程死亡1联体 (PD-L1),以增强免疫检查点抑制. 这些脂质-siPDL1s显示强烈抑制PD-L1表达,提供了一个有前途的新疗法策略.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

编程死亡1联体 (PD-L1) 是一种关键的免疫检查点分子,在癌细胞上表达,抑制T细胞功能.
目前的免疫检查点抑制剂,像抗体药物一样,面临临临床限制.
针对PD-L1提供了一种潜在的策略,以克服癌症诱导的免疫抑制.

研究的目的:

开发和评估一种针对PD-L1.1的新型脂类-siRNA结合抑制剂.
评估脂质-siPDL1s在抑制PD-L1表达中的有效性.
在诱导PD-L1过度表达的条件下研究脂质-siPDL1s的有效性.

主要方法:

开发一种旨在抑制PD-L1.1.的脂质-siRNA合物 (脂质-siPDL1s).
对脂质-siPDL1s对PD-L1mRNA表达的抑制作用的评估.
评估脂质-siPDL1s在用干扰素-amma刺激的癌细胞中的疗效.

主要成果:

脂类-siPDL1s显示强烈抑制PD-L1mRNA的表达.
脂-siPDL1s的抑制作用明显大于未经修改的siPDL1.1.
脂类-siPDL1s有效地抑制PD-L1表达,即使细胞被干扰素-amma刺激.

结论:

脂类-siPDL1s代表了一种新且有效的方法来抑制PD-L1表达.
这些脂类-siRNA结合体显示出作为下一代免疫检查点抑制剂的潜力.
开发的脂质-siPDL1s可以在癌症治疗中提供新的治疗途径.

关键词:

免疫检查点抑制剂免疫检查点抑制剂干扰素玛 (IFNγ) 的刺激核酸药物核酸药物是一种药物.编程死亡 1 连接体 (PD-L1)siRNA 结合体的结合体

更多相关视频

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy

Published on: June 21, 2013

相关概念视频

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...